This study investigated the diagnostic and prognostic values of kinesin superfamily proteins (KIFs) in breast cancer (BC) patients.
Background
Breast cancer (BC) remains the highest occurring cancer in women, in addition to being the third most frequent malignancy globally. In 2012, around 1.7 million persons worldwide had BC and nearly 500,000 died from the disease [1] [2] [3] [4] . One among eight or 10 women will develop BC in their lifetime. BC mortality has decreased in North America as well as the European Union, but is still increasing in South America, Africa, and Asia. BC is the most common cause of cancer mortality in developing countries, compared with lung cancer in developed countries [5] [6] [7] . Genetic aspects and environmental exposure play a significant part in the etiology of BC [8, 9] . The Human Genome Project has led to increasing attention being paid to cancer genetic susceptibility. A genetic factor which dysfunction amid normal tissues and tumors in the genome are the major potential sources of prognostic and diagnostic biomarkers [10] . Also, genes whose expression is interlinked with survival of BC might be prognostic biomarkers, as well as therapeutic targets [11] [12] [13] [14] . As in other malignant neoplastic diseases, BC is considered to have dysfunction of numerous gene signaling pathways as well as networks that have an impact on tissue homeostasis.
There are 45 kinesin superfamily proteins (KIFs) with various functions in humans [15] . KIFs are involved in the molecular movements of axonal transportation. KIFs are ubiquitous in eukaryotes, and some are involved in transportation of vesicles and organelles inside cells [16, 17] . KIF genes have been shown to play a crucial role in many tumors, and can be used to predict cancer diagnosis and prognosis [18, 19] . It has been shown that the KIF family of genes is linked with BC [20, 21] , nevertheless, the joint analysis linked with multiple KIF family genes regarding BC have rarely been recorded. Complete examination of the diagnostic and prognostic values of KIF genes in BC requires additional investigation. The purpose of the present study was to explore the diagnostic and prognostic values of KIF gene expression in BC patients, on the basis of bioinformatics evaluation.
Material and Methods

Bioinformatics analysis of KIF genes
For analysis of the biological pathways and significance of the KIF family genes, a set of functional enrichment analysis for the KIF family was performed using the Database for Annotation, Visualization and Integrated Discovery (DAVID 6.8, https://david.ncifcrf.gov/home.jsp, accessed August 3, 2018) . Enriched P values <0.05 were statistically significant. Gene-gene interactions of KIF family genes were investigated via GeneMANIA (http://www.genemania.org/, accessed August 9, 2018) [22] .
Protein-protein interactions were examined by the Search Instrument for the Retrieval of Interacting Genes/Proteins (STRING, https://string-db.org/, accessed August 9, 2018) [23] . We also applied the Cytoscape (version 3.6.1) Biological Networks Gene Ontology (BiNGO) instrument for performing Gene Ontology (GO) evaluation on the KIF gene family [24] .
Data source
The knowledge of the clinical of BC patients and RNA sequence based on the patients were gathered by the Cancer Genome Atlas (TCGA) database (https://cancergenome.nih.gov/, accessed June 7, 2018) . Using the edgeR package in R, we normalized mRNA sequencing data and examined mRNA expression in normal tissues and BC. Genes with an accustomed P value <0.01 and |log 2 fold-change (FC)| >2 were considered to be significantly different in BC and adjacent tissues. We regarded the genes as being differentially expressed mRNA (DEM). Clinical characteristics of patients with BC included gender, ethnicity (Asian, black, white or other), age at diagnosis (<65 or ³65 years), and tumor stage.
Survival analysis
For each KIF DEM, patients were divided into low-and highexpression groups according to the median expression values of each KIF genes. By utilizing survival curves by Kaplan-Meier analysis with log-rank test, we assessed the prognostic significance of every clinical aspect as well as DEM from a criterion of P<0.05. The Cox proportional hazards model was utilized for evaluating the comparative risk in such differentially expressed genes on overall survival (OS). The mRNAs significantly associated with OS in the Cox proportional hazards model were considered to be prognostic mRNAs.
Correlation analysis
Pearson correlation coefficient was assessed for identifying correlations between the prognostic mRNAs.
Joint-effects analysis and nomograms
To assess thoroughly the prognostic model, joint analysis and nomograms were performed on the KIF DEM prognostic signature. On the basis of previous survival analysis, we divided the combined genes into high-, intermediate-and low-risk groups, completed survival analysis on 3 groups of patients, and established a Cox regression model. In addition to the joint analysis, we examined the predictive prognostic value of the risk scoring using nomograms to assess the correlation among clinical status as well as risk score within BC OS. The possible implication of risk scoring on the basis of predicting clinical characteristics has similarly been discovered. C-index and calibration curve were considered with bootstrap self-sampling and internal verification.
Gene set enrichment analysis (GSEA)
The core concept in GSEA is to utilize a predefined group of genes (mainly by previous experimental outcomes or functional annotations) for ranking the genes in accordance with the extent of differential expression within the 2 types of samples, then verifying that the pre-established group of genes is supplemented at the bottom or top in the sorting table. To explore the differences in pathways as well as biological functions in the low-and high-expression sets of such prognostic KIF genes, GSEA (http://software.broadinstitute.org/gsea/index.jsp, accessed August 9, 2018) [25, 26] was used to explore potential KEGG pathway and GO analysis within the Molecular Signatures Database (MSigDB) of c2 (curated gene sets) and c5 (GO gene sets) [27] . The criteria for significant enrichment gene sets in GSEA were: P<0.05 and false discovery rate (FDR) <0.25.
Statistical analysis
Log-rank assessment was utilized for comparing clinical aspects as well as univariate survival analysis of KIF genes. Clinicopathological parameters statistically linked to OS (P<0.05) were included in multivariate Cox proportional hazard regression models to adjust. Hazard ratios (HRs) and 95% confidence intervals (CIs) were used to assess the relative risk in many patients with BC. Multiple testing with the Benjamini-Hochberg procedure was used to control the FDR in GSEA. Statistical analysis was performed using SPSS 22.0 and R 3.5.1 software. P<0.05 was considered to be statistically significant.
Results
Bioinformatics analysis of the KIF family genes
Enrichment analysis of GO terms for the KIF family genes, performed with DAVID, showed that KIF genes had suggestive enrichment for microtubule-based movement, and biological functions mainly included mitotic metaphase plate congression, mitotic cytokinesis, mitotic spindle assembly, cell division, mitotic spindle midzone assembly, and positive regulation of cytokinesis ( Figure 1 ). Gene-gene and protein-protein interaction networks confirmed that the KIF genes had solid protein homology as well as co-expression with one another at the protein as well as gene levels (Figure 2A, 2B) . The focused KIF genetic acyclic graph constructed by BiNGO in Cytoscape similarly showed that the main biological roles were cell cycle progression, cellular processes, and microtubule-based processes ( Figure 2C ). 
Patient characteristics influencing differential KIF expression in BC
The |log 2 FC| of KIF family is shown in a histogram ( Figure 3A) . Thirteen KIF family genes met the standard of FDR <0.05 together with |log 2 FC| ³2 (Table 1) . A scatter plot produced using TCGA showed the difference in expression of the 13 KIF genes in invasive BC tissues compared with normal breast tissues ( Figure 3B ). Therefore, only the remaining 13 mRNAs were included in the step function screening to investigate the optimal combination, and all the mRNA expression data were log 2 transformed for further analysis. The KIF genetic ROC analysis in the TCGA cohort specified that every KIF gene was highly accurate for discriminating normal breast and tumor tissues (area under the curve for the ROC curves in 11 KIF genes remained >0.9; Figure 4 , Table 1 ). 
, and KIF26B (K). KIF -kinesin; TCGA -the Cancer Genome Atlas; BC -breast cancer; AUC -area under the curve; ROC -receiver operating characteristic.
Survival analysis and association analysis
In the TCGA invasive BC cohort, patients with advanced tumor stage and age ³65 years had an increased risk of invasive BC mortality ( Table 2) . Other patient characteristics, including gender and race, within the TCGA cohort did not show a significant association with OS of invasive BC.
Survival analysis of the 13 differentially expressed KIF genes is shown in (Table 3 ) was related to poor OS within invasive BC, after adjusting for tumor stage and age.
After performing survival analysis within the TCGA cohorts, coexpression analysis of KIF15, KIF20A, KIF23, KIF2C and KIF4A in BC malignant tissues was evaluated using Pearson's correlation coefficient. The genes were co-expressed strongly with each other in the TCGA cohort ( Figure 6 ).
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Indexed (Tables 4-7 ). The Kaplan-Meier estimator with a log-rank evaluation was administered to evaluate the prognostic significance of the gene expression combinations represented by each group. Two selected groups showed that the BC patients with high expression of KIF20A and KIF4A or high expression of KIF2C and KIF4A had poor OS ( Table 8 ).
GSEA
GSEA of the prognostic genes KIF15, KIF20A, KIF23, KIF2C and KIF4A was performed within the TCGA cohorts. The expression profiles of the genome-wide dataset in the TCGA-based cohorts were divided into 2 groups in accordance with the median prognostic KIF genetic values. GSEA outcomes of the TCGA cohort are shown in Figures 7A-7L, 8A-8L and 9A-9F), which suggested that their elevated expression remained linked with mismatch repair, P53 regulation pathway, and cell cycle progression.
Nomogram analysis
The nomogram was driven from rms as well as its supplementary packages on the base of information of patients having BC with comprehensive clinical evidence within TCGA. It showed that, among the 5 KIF genes, KIF4A had the greatest sum of risk points (ranging between 0 and 100), while the other genes made a considerably lower contribution ( Figure 10A ). By examining the conformity and discrimination using the nomogram model, bootstrap analysis on the bases of 1000 resampling tests had a C-index of 0.76 and 95% CI of 0.70-0.82. The discrimination is suitable. The calibration curve showed that the general point was close to the ideal curve of 45 degrees, indicating good compliance ( Figure 10B , 10C). Table 3 . Prognostic survival analysis according to the high or low level of 13 diagnostic KIF genes and OS.
* Adjusted for age (stratified by 65 years) and tumor stage. KIF -kinesin; OS -overall survival; MST -median survival time; HR -hazard ratio; CI -confidence interval.
Discussion
Kinesin motor activity is spatially as well as temporally controlled within mitosis to ensure that it occurs precisely with stable inward and outward forces. Nevertheless, over-expression of a few mitotic kinesins might produce further outward forces. This provokes a sequence of undesirable events, such as overshooting before anaphase, sister chromatid segregation before anaphase, increased spindle separation, and ultimately monopolar or bipolar spindle formation [28. Such things might cause imbalanced distribution of DNA, aneuploidy and a plethora of cancer phenotypes, together with metastatic and invasive behavior. Kinesin function might cause failed cytokinesis, imperfect spindle assembly and mitotic arrest, which stimulates apoptosis and killing of cancer cells [15] . Our evaluation of genetic function enrichment suggested that the KIF gene family is involved in biological processes of the cell cycle such as mitotic cytokinesis, mitotic spindle assembly, and positive regulation of cytokinesis. Our analysis established that KIF15, KIF20A, KIF23, KIF2C and KIF4A were co-expressed at the protein and gene levels. We found 5 KIF genes of diagnostic and prognostic value. Extensive studies have reported these genes as potential diagnostic markers in multiple cancers. Among the 5 genes, KIF15 is likewise overexpressed in lung adenocarcinoma and might play a significant role in modifying the cell cycle [29] . Likewise, KIF15 promotes proliferation of pancreatic cancer cells via the MEK/ERK pathway [30] . KIF15 is overexpressed in BC cells and might have potential as a novel therapeutic target and a prognostic factor in endocrine-therapy-resistant BC [31] . We found that expression of KIF15 mRNA was significantly higher in BC than in adjacent tissues, and elevated expression of KIF15 in patients with BC was associated with poor OS. Our results agreed with previous studies that designated the KIF15 as an oncogene in BC.
In 2005, a study by Keisuke et al. [32] found that KIF20A was overexpressed in pancreatic cancer according to cDNA microarray analysis, and down-regulation of KIF20A significantly decreased tumor cell proliferation, confirming that KIF20A is carcinogenic in pancreatic cancer. Numerous studies have shown that KIF20A also has carcinogenic traits in various other cancers, such as nasopharyngeal carcinoma, liver cancer, melanoma, lung adenocarcinoma and glioma [33] . It has been suggested that the KIF20A gene is a potential diagnostic biomarker. We found that KIF20A has differential expression in BC and adjacent tissues, and high expression of KIF20A is related to poor OS in patients with BC, so it might also be a prognostic biomarker.
It has been found that KIF23 is up-regulated in patients with hepatocellular carcinoma, and it may be a marker for OS [34] . Zou et al. [31] showed that KIF4A, KIF15, KIF20A and KIF23 expression was significant in proliferating BC cells. They also showed that, among patients treated with tamoxifen, high expression of these 4 genes was highly correlated with poor recurrence-free survival. It has been suggested that over-expression of KIF23 is a valuable independent prognostic factor in lung tumors, particularly lung adenocarcinoma, and patients with p-stage I tumor stage and high expression of KIF23 have poorer survival than those with low expression [35] . In addition, the multivariate Cox proportional hazards model in our study, which was based on expression of KIF23, likewise divided patients in low-and high-expression groups, and patients with high expression had poor OS.
Nowadays, it is certain that KIF4A performs a significant role in cancer development and progression. Numerous studies have shown that KIF4A is a potential contributor to several malignant tumors, such as lung cancer [36] , breast cancer [37] , cervical cancer [38] , hepatocellular carcinoma [39] , and oral cancer [40] . Our results were consistent with previous studies. We also found that BC patients with high expression of KIF4A had poor OS compared with patients with low expression. (E-F) GSEA results of c5 reference gene sets for high KIF23 expression groups. KIF -kinesin; GSEA -gene set enrichment analysis; TCGA -the Cancer Genome Atlas; BC -breast cancer.
Shimo et al. have demonstrated that KIF2C is overexpressed in BC cells, and plays a major part in cytokinesis within these cells [41] . Additionally, they have discovered that down-regulation of KIF2C through treatment with siRNA suppresses development of BC cells [41] . We investigated the high expression of KIF4A, KIF15, KIF20A, KIF23 and KIF2C in patients in the TCGA database, which has been linked to poor OS. Our joint genetic analysis suggests that BC patients with high expression of 2-5 of these genes have poorer OS compared with patients with low gene expression. These findings suggest KIF4A, KIF15, KIF20A, KIF23 and KIF2C as potential prognostic biomarkers and therapeutic targets in BC.
GSEA showed that KIF4A, KIF15, KIF20A, KIF23 and KIF2C were significantly associated with the cell cycle, p53 and mismatch repair, that were associated with their biological functioning. It is well known that KIF genes play critical roles in DNA replication and cell cycle progression [15] . The results require additional experimental validation.
The present study had a few limitations. First, all the information was obtained from open databases, and the medical parameters were not complete. Therefore, we were not able to perform a far-reaching survival analysis of KIF genes, considering each latent prognostic variable of BC in the multivariate Cox proportional hazards regression model. Second, because of the varied origin of BC patients, together with the number of elements affecting BC prognosis, we were not able to construct a comprehensive hazard score model, which depended on the KIF genes articulation level for visualization forecast. Third, with the help of the correlation with the past research work, the constraint of our present investigation suggested that it just researched the relationship existing between the mRNA expression of the KIF genes and BC prognosis. Nonetheless, the connection between KIF protein level and BC requires additional investigation.
In spite of the above limitations, we established and validated the prognostic and diagnostic values of expression of KIF genes in BC patients, and similarly examined the potential mechanism linked with KIF4A, KIF15, KIF20A, KIF23 and KIF2C within BC prognosis by GSEA. When these outcomes are confirmed, the prognostic and diagnostic standards of KIF genetics on the extent of protein, such genes might hold a substantial clinical implication value in diagnosis of BC, as well as targeted therapy. Nevertheless, future verification with a larger study population is required to confirm that the KIF genes could be involved in diagnosis and prognostic monitoring of BC.
Conclusions
We revealed that 13 KIF genes were differentially expressed in BC tumor tissues, and may serve as latent diagnostic biomarkers in patients with BC. KIF15, KIF20A, KIF23, KIF2C and KIF4A have the potential to serve as prognostic biomarkers in patients with BC. Multivariate survival analysis, nomograms, and joint survival analysis showed high expression of these genes correlated with poor prognosis of BC. GO, KEGG and GSEA suggested that these genes affect the prognosis of BC by influencing the cell cycle. Our results need to be confirmed in further research. 
